Table 2a Correlation between baseline factors and serum sodium, cohort A
From: Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma
Serum sodium | |||
|---|---|---|---|
Low ( N =24) | Normal ( N =96) | P | |
MSKCC (N=115) | N (%) | N (%) | 0.001 |
Favourable (N=15) | 0 (0) | 15 (16) | |
Intermediate (N=65) | 8 (36) | 57 (61) | |
Poor (N=35) | 14 (64) | 21 (23) | |
Weight loss (N=119) | 0.001 | ||
⩽10% (N=95) | 13 (54) | 82 (86) | |
>10% (N=24) | 11 (46) | 13 (14) | |
Performance status (N=120) | 0.000 | ||
0.1 (N=91) | 8 (33) | 83 (86) | |
2+ (N=29) | 16 (67) | 13 (14) | |
Number of sites (N=120) | 0.020 | ||
1.2 (N=52) | 5 (21) | 47 (49) | |
3+ (N=68) | 19 (79) | 49 (51) | |
Primary tumor in place (N=120) | 0.039 | ||
No (N=59) | 7 (29) | 52 (54) | |
Yes (N=61) | 17 (71) | 44 (46) | |
Leukocytes (N=120) | 0.029 | ||
Normal (N=92) | 14 (58) | 78 (81) | |
High (N=28) | 10 (42) | 18 (19) | |
Albumin (N=119) | 0.000 | ||
Normal (N=68) | 2 (8) | 66 (69) | |
Low (N=51) | 22 (92) | 29 (31) | |
Alkalic phosphatase (N=118) | 0.004 | ||
Normal (N=71) | 7 (29) | 64 (67) | |
High (N=47) | 15 (63) | 32 (33) | |
Haemoglobin (N=120) | 0.000 | ||
Normal (N=56) | 2 (8) | 54 (56) | |
Low (N=64) | 22 (92) | 42 (44) | |
